RHO and retinal degeneration: In line with this hypothesis, other studies have also seen context dependent effects of the treatments: A read-through therapy using the aminoglycoside gentamycin in a rodent model for autosomal dominant RP (p.S334* in rhodopsin, transgenic rats) documented a significant amelioration of the retinal degeneration [45].